Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-10

Clinical Trial Update: Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the rivastigmine patch for postoperative delirium in patients at risk of dementia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine Patch (Rivastigmine)

Snippet

Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine | Conditions: Delirium | Phase 4 | Status: COMPLETED